Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

Robotic hair restoration is a safe, efficient alternative to manual hair transplant, best for men with dark, thick hair and skin, requiring sufficient donor hair and postoperative care.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Bridging anticoagulation may raise post-surgery bleeding risks.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Mast cells and VEGF contribute to post-surgery adhesions, and blocking VEGF can reduce these adhesions; also, certain factors affect wound healing and fetal skin heals differently with age.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.